Artery Therapeutics
UEI: JHVKQN55S7Y5
• CAGE: 62AP0
Overview
Awardee Type
Parent
Company Description
Artery Therapeutics, Inc. (ARTERY) is a pre-clinical stage biotechnology company developing effective treatments for neurodegenerative and metabolic diseases.
Name
Artery Therapeutics
Website
Headquarters
San Ramon, CA
United States
United States
Most Recent Award
Feb. 15, 2026
Calculating
Federal grant recipient
ARTERY THERAPEUTICS, INC.
dba ARTERY THERAPEUTICS INC
(UEI JHVKQN55S7Y5, CAGE 62AP0)
is headquartered in San Ramon CA.
Its primary registered NAICS is 541714 Research and Development in Biotechnology (except Nanobiotechnology).
The corporation
was founded in February 2004 and
federally registered in
July 2010.
Federal Award Analysis
Artery Therapeutics federal award history
$-
Contracts
$-
Subcontracts
$-
Grants
$-
Subgrants
$-
Total
No Results
Calculating
Calculating
No Results
Calculating
Calculating
No Results
Calculating
Calculating
| Year | Contracts | Subcontracts | Grants | Subgrants |
|---|
No Results
Calculating
Calculating
No Results
Calculating
Calculating
Federal Registration and Certifications
Legal Name
ARTERY THERAPEUTICS, INC.
DBA
ARTERY THERAPEUTICS INC
UEI
JHVKQN55S7Y5
CAGE Code
62AP0
SBA Certifications
None
Self Certifications
Self-Certified Small Disadvantaged Business
Entity Structure
Corporate Entity (Not Tax Exempt)
Purpose of Registration
Federal Contracts and Assistance
Date Founded
Feb. 19, 2004
Initial Registration
July 12, 2010
Last Registration
Aug. 26, 2025
Registration Activation
Aug. 26, 2025
Registration Expiration
Aug. 22, 2026
Fiscal Year End
December 31
Reported Entity Types
For Profit Organization
State of Incorporation
DE
Country of Incorporation
USA
Employees
<500
Accepts Credit Cards
No
People
Vendor contacts at Artery Therapeutics
Grant Awards
Artery Therapeutics direct grants
Teaming Partners
Disclosed awardee sub and prime contract and grant relationships
Artery Therapeutics